This approach allowed us to identify more cases of AITL, and more stringent morphological criteria allowed us to identify hallmark cells with strong expression of Ki-1 (CD30), which was essential for differentiating ALK-negative ALCL from CD30+ PTCL-NOS. The gene discussed is ALK; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.